Publication | Closed Access
GLP-1 derivatives as novel compounds for the treatment of type 2 diabetes: Selection of NN2211 for clinical development
35
Citations
0
References
2001
Year
Glp-1 DerivativesDiabetes ManagementMedicineDrug DiscoveryDiabetesType 2Clinical DevelopmentDiabetes MellitusPharmacologyBiomolecular Engineering
No additional data available for this publication yet. Check back later!